Bryn Mawr Trust CO Harmony Biosciences Holdings, Inc. Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 146 shares of HRMY stock, worth $5,045. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146
Previous 146
-0.0%
Holding current value
$5,045
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$229 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$164 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$78.8 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...